Anxious wait for cystic fibrosis PBS announcement

17 August 2018 - The outcomes from the July 2018 PBAC meeting with be made public later today. ...

Read more →

Public Summary Documents – March 2018 PBAC meeting

13 July 2018 - The Public Summary Documents (first time rejections and deferrals) from the March 2018 PBAC meeting are now ...

Read more →

PBAC rejects first submission supported by real-world evidence

4 July 2018 - A retrospective chart review of 211 Australian patients with chronic migraine served as the key evidentiary basis ...

Read more →

Recommendations made by the PBAC - April 2018

1 June 2018 - The recommendations from the April 2018 PBAC meeting are now available. ...

Read more →

'It's magic': families, advocates celebrate lifesaving drug announcement

7 May 2018 - It’s not a cure, but for Bethan McElwee the drug Spinraza is the difference between her ...

Read more →

Insights from the March 2018 PBAC meeting

26 April 2018 - Analysis of the outcomes from the March 2018 PBAC meeting reveals some interesting findings. ...

Read more →

Summary of submissions and outcomes from the March 2018 PBAC meeting

23 April 2018 - 71 submissions were considered by the PBAC; 66 relate to the listing of a medicine, medicinal ...

Read more →

Recommendations made by the PBAC - March 2018

20 April 2018 - The recommendations from the March 2018 PBAC meeting are now available. ...

Read more →

Government subsidises two $5000/month breast cancer drugs

21 April 2018 - Women fighting breast cancer will no longer face treatment bills in the tens of thousands of ...

Read more →

Public Summary Documents - November 2017 PBAC meeting

16 March 2018 - The Public Summary Documents (first time rejections and deferrals) from the November 2017 PBAC meeting are now ...

Read more →

Anti-HIV pill set for federal drug scheme

9 February 2018 - An anti-HIV drug has been officially recommended to be added to the Pharmaceutical Benefits Scheme. ...

Read more →

Recommendations made by the PBAC - December 2017

9 February 2018 - The recommendations from the December 2017 PBAC meeting are now available. ...

Read more →

Subsidy for HIV prevention drug PrEP to slash cost from 10,000 dollars a year to just 474 dollars

8 February 2018 - Drug that reduces risk of infection expected to be added to Pharmaceutical Benefits Scheme. ...

Read more →

Nusinersen: 'amazing' spinal muscular atrophy drug rejected for Pharmaceutical Benefits Scheme

20 December 2017 - They were hoping for an early Christmas present, but instead the families of children with spinal ...

Read more →

Pharmaceutical Benefits Advisory Committee recommendations in Australia

16 December 2017 - The aim of this study was to examine submissions made to the PBAC and assess whether the ...

Read more →